Patents by Inventor Josep Martí Via

Josep Martí Via has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IVABRADINE HYDROCHLORIDE FORM IV
    Publication number: 20160289192
    Abstract: Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient and pharmaceutical compositions containing Ivabradine hydrochloride Form IV.
    Type: Application
    Filed: April 2, 2016
    Publication date: October 6, 2016
    Inventors: Rafael Prohens Lopez, Cristina Puigjaner Vallet, Rafael Barbas Canero, Jose Luis Del Rio Pericacho, Josep Marti Via
  • Process for preparating ivabradine hydrochloride form IV and methods of treatment of disease using ivabradine hydrochloride form IV
    Patent number: 9309201
    Abstract: Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient and pharmaceutical compositions containing Ivabradine hydrochloride Form IV.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: April 12, 2016
    Assignee: URQUIMA, S.A.
    Inventors: Rafael Prohens Lopez, Cristina Puigjaner Vallet, Rafael Barbas Canero, Jose Luis Del Rio Pericacho, Josep Marti Via
  • PROCESS FOR PREPARATING IVABRADINE HYDROCHLORIDE FORM IV AND METHODS OF TREATMENT OF DISEASE USING IVABRADINE HYDROCHLORIDE FORM IV
    Publication number: 20150344435
    Abstract: Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient and pharmaceutical compositions containing lvabradine hydrochloride Form IV.
    Type: Application
    Filed: July 22, 2015
    Publication date: December 3, 2015
    Applicant: URQUIMA, S.A.
    Inventors: Rafel Prohens Lopez, Cristina Puigjaner Vallet, Rafael Barbas Canero, Jose Luis Del Rio Pericacho, Josep Marti Via
  • Ivabradine hydrochloride form IV
    Patent number: 9139531
    Abstract: Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: September 22, 2015
    Assignee: URQUIMA, S.A.
    Inventors: Rafel Prohens Lopez, Cristina Puigjaner Vallet, Rafael Barbas Canero, Jose Luis Del Rio Pericacho, Josep Marti Via
  • IVABRADINE HYDROCHLORIDE FORM IV
    Publication number: 20140315890
    Abstract: Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient.
    Type: Application
    Filed: September 21, 2012
    Publication date: October 23, 2014
    Inventors: Rafel Prohens Lopez, Cristina Puigjaner Vallet, Rafael Barbas Canero, Jose Luis Del Rio Pericacho, Josep Marti Via
  • 4-aminopyrimidine derivatives as histamine Hreceptor antagonists
    Patent number: 8431580
    Abstract: 4-Aminopyrimidine derivatives of formula (I) that are useful as histamine H4 receptor antagonists.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: April 30, 2013
    Assignee: Palau Pharma, S.A.
    Inventors: Elena Carceller González, Eva Maria Medina Fuentes, Robert Soliva Soliva, Marina Virgili Bernadó, Josep Martí Via
  • 4-AMINOPYRIMIDINE DERIVATIVES AS HISTAMINE H4 RECEPTOR ANTAGONISTS
    Publication number: 20110039817
    Abstract: 4-Aminopyrimidine derivatives of formula (I) that are useful as histamine H4 receptor antagonists.
    Type: Application
    Filed: December 18, 2008
    Publication date: February 17, 2011
    Inventors: Elena Carceller González, Eva María Medina Fuentes, Robert Soliva Soliva, Marina Virgili Bernadó, Josep Martí Via
  • 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
    Publication number: 20090306038
    Abstract: 2-Aminopyrimidine derivatives of formula (I) that are useful as modulators of the H4 receptor.
    Type: Application
    Filed: September 12, 2006
    Publication date: December 10, 2009
    Inventors: Elena Carceller González, Jorge Salas Solana, Robert Soliva Soliva, Eva Maria Medina Fuentes, Josep Marti Via